SLU-PP-332 – High-Purity Research Compound - 250mcg -100 Tablets

SLU-PP-332 is a synthetic small-molecule compound investigated in laboratory settings for its activity as an estrogen-related receptor (ERR) agonist, particularly targeting ERRα and ERRγ. In controlled research environments, it has been studied for its potential role in mitochondrial biogenesis, oxidative metabolism and cellular energy regulation.

Manufactured under strict quality controls, SLU-PP-332 is supplied in tablet form and independently verified at >99.1% purity (HPLC-tested). Each batch is provided with a full Certificate of Analysis (COA) to ensure transparency, consistency and reproducibility across research applications.

What is SLU-PP-332?

SLU-PP-332, chemically known as (E)-4-Hydroxy-N′-(naphthalen-2-ylmethylene)benzohydrazide, is a non-hormonal ERR agonist explored in preclinical research models to better understand transcriptional regulation linked to mitochondrial function and cellular energy expenditure.

Usage & Storage

SLU-PP-332 is supplied in tablet form for ease of handling in laboratory environments and should be used in accordance with established research protocols. Store in a sealed container, protected from light and moisture to maintain product integrity.

For laboratory research use only.

⸻

Research Areas of Interest

Preclinical and laboratory studies have explored SLU-PP-332 in relation to several biological pathways, including:

Mitochondrial Biogenesis Research
Investigated for its influence on mitochondrial gene expression and cellular energy production pathways.

Energy Metabolism Models
Studied for its interaction with oxidative capacity and metabolic signalling in controlled research environments.

ERRα / ERRγ Signalling Studies
Used to examine transcriptional pathways associated with estrogen-related receptors, independent of classical estrogen receptor activity.

This product is supplied strictly for laboratory research purposes only.